Tag Archives: Treatment

Allopregnanolone Sparks Interest in New PMDD Treatment

Allopregnanolone is all over the place these days.  We have seen several different allopregnanolone derivatives being used to treat postpartum depression (PPD).  Last year, intravenous brexanolone (Zulresso) was approved by the FDA as the first treatment specifically for postpartum depression.  An oral version of allopregnanolone, called zuranolone, is also being pursued as a treatment for… Read More »

FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia

FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia Print this page MORRISTOWN, N.J., Jan. 29, 2020 /PRNewswire/ — Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) injection 100 mg/mL.  Monoferric® is an intravenous iron indicated for the treatment of iron… Read More »

Many people living with HIV unwilling to interrupt treatment for prolonged periods during HIV cure trials

A study assessing the opinions of people living with HIV and their healthcare providers about analytic treatment interruptions (ATIs) has found that patients had limited understanding of how ATIs are usually conducted in HIV cure studies. These findings are reported by Dr Jillian Lau and colleagues in AIDS Research and Retroviruses. Treatment interruptions pose potential… Read More »

FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults

FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults Print this page PANGYO, South Korea and PARAMUS, N.J., Nov. 21, 2019 /PRNewswire/ — SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and bringing treatments to market for central nervous system (CNS) disorders, and its U.S. subsidiary SK Life… Read More »